DERMATOPLEX

Serial Number 79377981
686

Registration Progress

Application Filed
Jul 31, 2023
Under Examination
Approved for Publication
Jun 3, 2025
Published for Opposition
Jun 3, 2025
Registered

Trademark Image

DERMATOPLEX

Basic Information

Serial Number
79377981
Filing Date
July 31, 2023
Published for Opposition
June 3, 2025
Drawing Code
5

Status Summary

Current Status
Active
Status Code
686
Status Date
Jun 3, 2025
Application
Pending
Classes
001 005 010 042
+1 more

Rights Holder

SpeeDx Pty Ltd

99
Address
Suite 102, National Innovation Centre,
Australian Technology Park, 4 CornwallisStreet Eveleigh NSW 2015
AU

Ownership History

SpeeDx Pty Ltd

Original Applicant
99
AU

SpeeDx Pty Ltd

Owner at Publication
99
AU

Legal Representation

Attorney
Jefferson F. Scher

USPTO Deadlines

No Upcoming Deadlines

No upcoming deadlines found for this trademark.

Application History

35 events
Date Code Type Description
Jun 3, 2025 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jun 3, 2025 PUBO A PUBLISHED FOR OPPOSITION
May 28, 2025 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
May 5, 2025 CNSA O APPROVED FOR PUB - PRINCIPAL REGISTER
May 4, 2025 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED
May 4, 2025 ERFR I TEAS REQUEST FOR RECONSIDERATION RECEIVED
May 4, 2025 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 1, 2025 OPNX P NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Feb 11, 2025 CNFR R FINAL REFUSAL WRITTEN
Feb 11, 2025 GNFR O FINAL REFUSAL E-MAILED
Feb 11, 2025 GNFN O NOTIFICATION OF FINAL REFUSAL EMAILED
Feb 10, 2025 OPNS P NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Feb 9, 2025 OPNR P NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Jan 13, 2025 DOCK D ASSIGNED TO EXAMINER
Oct 23, 2024 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED
Oct 23, 2024 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED
Oct 23, 2024 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE
Oct 22, 2024 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Oct 22, 2024 CHAN I APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Oct 22, 2024 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Oct 22, 2024 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED
Oct 22, 2024 COAR I TEAS CHANGE OF OWNER ADDRESS RECEIVED
Oct 22, 2024 ECDR I TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Aug 12, 2024 ATRV O ATTORNEY REVIEW COMPLETED
Jul 7, 2024 LIME X LIMITATION FROM THE IB - REQUEST EXAM REVIEW
May 13, 2024 RFNT P REFUSAL PROCESSED BY IB
May 12, 2024 LIMG M LIMITATION OF GOODS RECEIVED FROM IB
Apr 24, 2024 RFCS P NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Apr 23, 2024 RFRR P REFUSAL PROCESSED BY MPU
Apr 4, 2024 RFCR E NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Apr 3, 2024 CNRT R NON-FINAL ACTION WRITTEN
Apr 1, 2024 DOCK D ASSIGNED TO EXAMINER
Sep 12, 2023 MAFR O APPLICATION FILING RECEIPT MAILED
Sep 8, 2023 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sep 7, 2023 REPR M SN ASSIGNED FOR SECT 66A APPL FROM IB

Detailed Classifications

Class 001
Chemical reagents for non-medical purposes; chemical reagents for scientific purposes; chemical solutions and preparations consisting of pre-mixed reactants and reagents for scientific and research use in connection with amplification, analysis or labeling of nucleic acid; enzyme preparations for industrial purposes to identify pathogens, infections, and infectious diseases; enzymes for scientific and research purposes; nucleic acids for scientific purposes; nucleic recombinant acids for scientific purposes; acids, namely, nucleic recombinant acids to identify pathogens, infections, and infectious diseases for scientific purposes; polymerase for scientific purposes; none of the foregoing for use in promoting plant growth or in enhancing the effectiveness of plant nutrients
Class 005
Reagents for medical and veterinary use; nucleic acid amplification reagents for medical use; nucleic acid sequencing programs for medical use to identify pathogens, infections, and infectious diseases; chemical preparations containing enzymes for medical purposes for treating infections and infectious diseases; chemical preparations containing enzymes for treating infections and infectious diseases for pharmaceutical, veterinary and medical purposes; enzyme preparations for pharmaceutical, veterinary and medical purposes; diagnostic kits comprised of medical diagnostic reagents and assays for testing of bodily fluids for use in disease detection, namely, to diagnose and identify pathogens, infections, and infectious diseases; diagnostic kits comprising diagnostic agents, preparations and substances for medical and veterinary use; diagnostic kits comprised of medical diagnostic reagents and assays for medical laboratory use in analysis of gene expression, protein expression, metabolite expression, inflammation, immune-suppression, immune disorders, all for testing of bodily fluids for use in disease detection, namely, to diagnose and identify pathogens, infections, and infectious diseases; none of the foregoing for use in or as a medicated shampoo
Class 010
Surgical, medical and veterinary apparatus and instruments for diagnosis of disease, for detection and identification of pathogens, for the detection of antibiotic resistance, for the analysis of gene expression, protein expression, metabolic expression, inflammation, and immune-suppression and immune disorders for genotyping, analysis of polymorphisms, detection of acquired or inherited genetic mutations, detection and analysis of epigenetic alterations, analysis of response to therapy for treatment of infectious diseases, immunological diseases and autoimmune diseases; diagnostic testing apparatus and instruments for medical purposes, namely, for diagnosis of disease, for detection and identification of pathogens, for the detection of antibiotic resistance, for the analysis of gene expression, protein expression, metabolic expression, inflammation, and immune-suppression and immune disorders for genotyping, analysis of polymorphisms, detection of acquired or inherited genetic mutations, detection and analysis of epigenetic alterations, analysis of response to therapy for treatment of infectious diseases, immunological diseases and autoimmune diseases; medical diagnostic apparatus for testing for diagnosis of disease, for detection and identification of pathogens, for the detection of antibiotic resistance, for the analysis of gene expression, protein expression, metabolic expression, inflammation, and immune-suppression and immune disorders for genotyping, analysis of polymorphisms, detection of acquired or inherited genetic mutations, detection and analysis of epigenetic alterations, analysis of response to therapy for treatment of infectious diseases, immunological diseases and autoimmune diseases; point of care medical devices, namely, a device for testing for diagnosis of disease, for detection and identification of pathogens, for the detection of antibiotic resistance, for the analysis of gene expression, protein expression, metabolic expression, inflammation, and immune-suppression and immune disorders for genotyping, analysis of polymorphisms, detection of acquired or inherited genetic mutations, detection and analysis of epigenetic alterations, analysis of response to therapy for treatment of infectious diseases, immunological diseases and autoimmune diseases; diagnostic kits consisting primarily of probes, buffers and reagents for use in microbial testing; Anatomic pathology specimen collection kit comprising glass slides, centrifuge tubes, formalin jars, coplin jars, insert to hold slides and jars, absorbent cloth, and printed instructions, all for medical use
Class 042
Scientific research in the field of genetics; scientific research in the field of genetics and genetic engineering; research and development services in the field of chemistry; scientific research in the field of chemistry; research in the field of chemistry; research laboratory analysis services in the field of chemistry; development services in the field of medical diagnostic apparatuses; design of medical diagnostic apparatuses; research in the field of molecular sciences; data analysis for scientific research purposes in the field of scientific and medical experiments and tests; biological, bacteriological, chemical, biochemical, DNA, RNA, protein, polynucleic acid and molecular analysis and evaluation services, for scientific research purposes; DNA and RNA and polynucleic acid and protein sequencing, analysis and evaluation services for scientific research purposes; genome sequencing services and the analysis and evaluation of data resulting therefrom for scientific research purposes; providing reports relating to scientific and medical experiments, the results of scientific and medical experiments and tests, the analysis and evaluation of scientific and medical data, and data generated by scientific and medical experiments and tests; scientific and medical research and development services, for scientific research purposes; custom design and development of biochemical assays
Class 044
Medical services; human healthcare services in the field of diagnosis and identification of pathogens infections and infectious diseases; medical testing services relating to the diagnosis and treatment of disease; genetic testing for medical purposes; medical and health services in the field of DNA and genetic testing; medical diagnostic services in the nature of medical testing and analysis; molecular diagnostics testing for medical purposes; providing medical information in the field of genetic and treatment information for diseases and disorders for diagnostic and treatment purposes; analysis of medical diagnostic images and medical molecular tests for medical purposes

Additional Information

Design Mark
The mark consists of the stylized wording "DERMATOPLEX".

Classification

International Classes
001 005 010 042 044